Literature DB >> 21649455

Management of irritable bowel syndrome (IBS) in adults: conventional and complementary/alternative approaches.

Saunjoo L Yoon1, Oliver Grundmann, Laura Koepp, Lana Farrell.   

Abstract

Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder with a range of symptoms that significantly affect quality of life for patients. The difficulty of differential diagnosis and its treatment may significantly delay initiation of optimal therapy. Hence, persons with IBS often self-treat symptoms with non-prescribed pharmacological regimens and/or complementary and alternative medicines (CAM) and by modifying diet and daily activities. In addition, most common pharmacological approaches target IBS symptom management rather than treatment, and prescribed medications often result in significant side effects. The purposes of this review article are to: (1) address current issues related to IBS, including symptom presentation, diagnosis, and current treatment options; (2) summarize benefits and side effects of currently available pharmacological regimens and other symptom management strategies, with an emphasis on commonly used CAM therapies and diet modification; and (3) outline recommendations and future directions of IBS management based on systematic reviews, meta-analyses, and research findings.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21649455

Source DB:  PubMed          Journal:  Altern Med Rev        ISSN: 1089-5159


  17 in total

1.  Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.

Authors:  Young Ah Goo; Kevin Cain; Monica Jarrett; Lynne Smith; Joachim Voss; Ernie Tolentino; Joyce Tsuji; Yihsuan S Tsai; Alexandre Panchaud; David R Goodlett; Robert J Shulman; Margaret Heitkemper
Journal:  J Proteome Res       Date:  2012-10-26       Impact factor: 4.466

Review 2.  Treatment of irritable bowel syndrome in China: a review.

Authors:  Chun-Yan Li; Shu-Chuen Li
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

3.  Pain management in patients with inflammatory bowel disease: insights for the clinician.

Authors:  Arvind Iyengar Srinath; Chelsea Walter; Melissa C Newara; Eva M Szigethy
Journal:  Therap Adv Gastroenterol       Date:  2012-09       Impact factor: 4.409

4.  Essential Oil Education for Health Care Providers.

Authors:  Rebecca Boesl; Heidi Saarinen
Journal:  Integr Med (Encinitas)       Date:  2016-12

Review 5.  Complementary and alternative medicines in irritable bowel syndrome: an integrative view.

Authors:  Oliver Grundmann; Saunjoo L Yoon
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 6.  Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine.

Authors:  Lekha Saha
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

7.  Research Design Characteristics of Published Pharmacologic Randomized Clinical Trials for Irritable Bowel Syndrome and Chronic Pelvic Pain Conditions: An ACTTION Systematic Review.

Authors:  Jennifer S Gewandter; Jenna Chaudari; Katarzyna B Iwan; Rachel Kitt; Sawsan As-Sanie; Gloria Bachmann; Quentin Clemens; H Henry Lai; Frank Tu; G Nicholas Verne; Katy Vincent; Ursula Wesselmann; QiQi Zhou; Dennis C Turk; Robert H Dworkin; Shannon M Smith
Journal:  J Pain       Date:  2018-02-02       Impact factor: 5.820

8.  Antimuscarinic use among older adults with dementia and overactive bladder: a Medicare beneficiaries study.

Authors:  Nandita Kachru; Holly M Holmes; Michael L Johnson; Hua Chen; Rajender R Aparasu
Journal:  Curr Med Res Opin       Date:  2021-05-13       Impact factor: 2.705

9.  Calea zacatechichi dichloromethane extract exhibits antidiarrheal and antinociceptive effects in mouse models mimicking irritable bowel syndrome.

Authors:  M Sałaga; A Kowalczuk; M Zielinska; A Błażewicz; J Fichna
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-06-12       Impact factor: 3.000

10.  Comparison of the antibacterial activity of essential oils and extracts of medicinal and culinary herbs to investigate potential new treatments for irritable bowel syndrome.

Authors:  Aiysha Thompson; Dilruba Meah; Nadia Ahmed; Rebecca Conniff-Jenkins; Emma Chileshe; Chris O Phillips; Tim C Claypole; Dan W Forman; Paula E Row
Journal:  BMC Complement Altern Med       Date:  2013-11-28       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.